Mandate

Vinge has advised KKR in connection with the acquisition of Gunnebo Industrier

May 22, 2019 M&A

Vinge has advised the global investment company, KKR in connection with the acquisition by its portfolio company Crosby of Gunnebo Industrier from Segulah and minority investors.

Crosby is a global, market‑leading company with products within lifting and rigging. Gunnebo Industrier is an international manufacturing group that provides lifting and material handling products to a global customer base. The company was founded in 1764 and has manufacturing units in Sweden, Norway and the USA with subsidiaries in nine countries and distribution partners in more than 50 countries.

Vinge’s team consisted of, among others, Christina Kokko, Samra Baytar, Marith Welin-Berger and Hanna Risberg (Corporate and M&A), Adriana Berglund and Michael Montner (Commercial Agreements), Lisa Ullman (Employment), André Isacson and Josefine Larsson (Banking and Finance), Klara Secher and Hannah Kajlinger (IP), Kristoffer Larson (Real Property), Agnes Perbo and Nicklas Thorgerzon (IT) and Jessica Öijer (VDR assistant).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026